3BILLION INC.

Company Overview

Founded as a spinoff from Macrogen, 3billion is an AI technology-based genetic testing company offering direct-to-consumer (DTC) genomic rare disease screening tests. 3billion analyzes rare genetic diseases caused by specific genetic mutations. The company's ML-based automated variant interpretation system reduces the time and cost needed for rare disease diagnosis. 3billion rapidly expands its global presence, with overseas sales making up 60% of its revenue. The company also markets its rare disease genomic database products to companies doing clinical research and rare disease drug development.

Company's Business Segments

• Product : 3B-GENOME, 3B-EXOME, 3B-VARIANT, 3B-INTERPRETER, Others
• Services : Genetic Testing Services, Pharmaceutical and Biotech collaborations, Others